Moolec Science S.A. (MLEC) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Moolec Science S.A. (MLEC:NASDAQ), powered by AI.

Current Price
$7.86
P/E Ratio
-0.0
Market Cap
3M
Sector
Healthcare
What is the Moolec Science S.A. stock price forecast?

Moolec Science S.A. is currently trading at $7.86. View real-time AI analysis on Alpha Lenz.

What is Moolec Science S.A. insider trading activity?

View the latest insider trading data for Moolec Science S.A. on Alpha Lenz.

What is Moolec Science S.A.'s P/E ratio?

Moolec Science S.A.'s P/E ratio is -0.0.

Moolec Science S.A.

NASDAQ · MLEC
$7.86+0.23(+3.01%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Moolec Science S.A.'s future dividend policy...
Alpha Chat Insight

Moolec Science S.A. trades at a P/E of -0.0 (undervalued) with strong ROE of 344.2%.

Ask for details

Company Overview

Moolec Science S.A. is a forward-thinking biotechnology company focused on revolutionizing the agri-food sector through molecular farming techniques. Primarily, Moolec aims to blend plant and animal biology to produce animal proteins using plant-based systems, offering an innovative solution to traditional livestock farming. These proteins are developed to retain the nutritional value and taste profile of animal-derived proteins, targeting application in the food industry to cater to growing demands for sustainable and ethical food options. The company operates at the intersection of agriculture and biology, impacting industries that prioritize environmental sustainability and efficient food production processes. By using plants as bioreactors, Moolec Science strives to offer scalable and climate-friendly alternatives to conventional protein sources. The company's technology holds potential significance in reducing the environmental footprint of protein production, which is increasingly gaining importance in global sustainability agendas. Moolec Science S.A.’s efforts contribute to the broader biotech landscape by enabling cleaner production methods in alignment with global agricultural and nutritional trends.

CEOMr. Gaston Paladini M.B.A.
SectorHealthcare
IndustryBiotechnology
Employees52

Company Statistics

FY 2025

Profile

$3.39MMarket Cap
$333.61MRevenue
0.00Shares Out
52Employees

Margins

37.69%Gross
-22.27%EBITDA
-1.05%Operating
-50.96%Pre-Tax
-52.95%Net

Valuation

-0.03P/E
-0.05P/B
0.01EV/Sales
-3.13EV/EBITDA
-0.31P/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-30.60%ROA
344.24%ROE
-22.85%ROIC

Financial Health

$767.92KCash & Cash Equivalents
$286.82MNet Debt
-347.01%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Moolec Science S.A. (ticker: MLEC) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 52 employees. Market cap is $3M.

The current price is $7.86 with a P/E ratio of -0.03x and P/B of -0.05x.

ROE is 344.24% and operating margin is -1.05%. Annual revenue is $334M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Moolec Science S.A. (MLEC) Stock Forecast 2026 $7.86 — Price, Financials & Analyst Targets | Alpha Lenz